CN107427564A - 免疫原性/治疗性糖缀合物组合物及其用途 - Google Patents

免疫原性/治疗性糖缀合物组合物及其用途 Download PDF

Info

Publication number
CN107427564A
CN107427564A CN201580062962.2A CN201580062962A CN107427564A CN 107427564 A CN107427564 A CN 107427564A CN 201580062962 A CN201580062962 A CN 201580062962A CN 107427564 A CN107427564 A CN 107427564A
Authority
CN
China
Prior art keywords
klh
leu
composition
asp
ala
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201580062962.2A
Other languages
English (en)
Chinese (zh)
Inventor
游丞德
谢义簧
陈怡如
李威汉
王南绚
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
OBI Pharma Inc
Original Assignee
OBI Pharma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by OBI Pharma Inc filed Critical OBI Pharma Inc
Publication of CN107427564A publication Critical patent/CN107427564A/zh
Pending legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/0005Vertebrate antigens
    • A61K39/0011Cancer antigens
    • A61K39/001169Tumor associated carbohydrates
    • A61K39/001173Globo-H
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/0005Vertebrate antigens
    • A61K39/0011Cancer antigens
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/385Haptens or antigens, bound to carriers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/39Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/04Immunostimulants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/555Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511Organic adjuvants
    • A61K2039/55577Saponins; Quil A; QS21; ISCOMS
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/57Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2
    • A61K2039/575Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2 humoral response
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/60Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
    • A61K2039/6031Proteins
    • A61K2039/6081Albumin; Keyhole limpet haemocyanin [KLH]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/62Medicinal preparations containing antigens or antibodies characterised by the link between antigen and carrier
    • A61K2039/627Medicinal preparations containing antigens or antibodies characterised by the link between antigen and carrier characterised by the linker
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/64Medicinal preparations containing antigens or antibodies characterised by the architecture of the carrier-antigen complex, e.g. repetition of carrier-antigen units
    • A61K2039/645Dendrimers; Multiple antigen peptides
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2317/00Immunoglobulins specific features
    • C07K2317/10Immunoglobulins specific features characterized by their source of isolation or production
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2317/00Immunoglobulins specific features
    • C07K2317/20Immunoglobulins specific features characterized by taxonomic origin
    • C07K2317/21Immunoglobulins specific features characterized by taxonomic origin from primates, e.g. man

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Preparation (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CN201580062962.2A 2014-09-15 2015-09-15 免疫原性/治疗性糖缀合物组合物及其用途 Pending CN107427564A (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201462050567P 2014-09-15 2014-09-15
US62/050,567 2014-09-15
PCT/US2015/050270 WO2016044326A1 (en) 2014-09-15 2015-09-15 Immunogenic/therapeutic glycoconjugate compositions and uses thereof

Publications (1)

Publication Number Publication Date
CN107427564A true CN107427564A (zh) 2017-12-01

Family

ID=55533765

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201580062962.2A Pending CN107427564A (zh) 2014-09-15 2015-09-15 免疫原性/治疗性糖缀合物组合物及其用途

Country Status (18)

Country Link
US (1) US20160339089A1 (ja)
EP (1) EP3193919B1 (ja)
JP (1) JP6774941B2 (ja)
KR (2) KR20230109783A (ja)
CN (1) CN107427564A (ja)
AR (1) AR101871A1 (ja)
AU (1) AU2015317889B2 (ja)
BR (1) BR112017005120B1 (ja)
CA (1) CA2961522A1 (ja)
CL (1) CL2017000625A1 (ja)
ES (1) ES2797747T3 (ja)
IL (1) IL251120B (ja)
MY (1) MY188880A (ja)
PH (1) PH12017500478A1 (ja)
RU (1) RU2720295C2 (ja)
SG (1) SG11201702037SA (ja)
TW (1) TWI726850B (ja)
WO (1) WO2016044326A1 (ja)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN108350605A (zh) 2015-09-04 2018-07-31 台湾浩鼎生技股份有限公司 聚糖阵列以及使用方法
US10980894B2 (en) 2016-03-29 2021-04-20 Obi Pharma, Inc. Antibodies, pharmaceutical compositions and methods
AU2017239637A1 (en) 2016-03-29 2018-11-15 Obi Pharma, Inc. Antibodies, pharmaceutical compositions and methods
BR112018071683A2 (pt) * 2016-04-22 2019-02-19 Obi Pharma, Inc. método para tratar um câncer de mama, método para tratamento de um tumor em um paciente, método para tratar um indivíduo sofrendo com câncer por imunoterapia, método para induzir/melhorar uma resposta imune em um indivíduo, método para melhorar a vacina obi-822 induzida pela resposta imune em um indivíduo necessitando da mesma, método para identificar um paciente adequado para terapia do câncer e método para determinar o prognóstico do tratamento do câncer ou resposta do fármaco de um paciente
WO2018022933A1 (en) * 2016-07-27 2018-02-01 Obi Pharma, Inc. Immunogenic/therapeutic glycan compositions and uses thereof
US11643456B2 (en) 2016-07-29 2023-05-09 Obi Pharma, Inc. Human antibodies, pharmaceutical compositions and methods
WO2018094414A1 (en) 2016-11-21 2018-05-24 Obi Pharma, Inc. Conjugated biological molecules, pharmaceutical compositions and methods
EP3775894B1 (en) * 2018-05-11 2024-04-24 OBI Pharma, Inc. Method for predicting human immune response
TW202035444A (zh) 2018-06-27 2020-10-01 台灣浩鼎生技股份有限公司 用於糖蛋白工程的糖苷合成酶變體及其使用方法

Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040208884A1 (en) * 1999-08-20 2004-10-21 Danishefsky Samuel J. Clustered multi-antigenic carbohydrate constructs, methods for their preparation, and uses thereof
EP1527081A1 (en) * 2002-07-31 2005-05-04 Sloan-Kettering Institute For Cancer Research Glyconjugates comprising carbohydrate epitopes, methods for theirsynthesis, and their use for the treatment or prophylaxis of cancer
US20100136042A1 (en) * 2008-06-16 2010-06-03 Chi-Huey Wong Globo h and related anti-cancer vaccines with novel glycolipid adjuvants
CN102215862A (zh) * 2009-06-16 2011-10-12 中央研究院 Globo h及含新颖糖脂质佐剂的相关抗癌疫苗
US20120237532A1 (en) * 2011-03-15 2012-09-20 Icon Genetics Gmbh Pharmaceutical formulation containing immunoglobulin
WO2014107652A2 (en) * 2013-01-04 2014-07-10 Obi Pharma Vaccines with higher carbohydrate antigen density and novel saponin adjuvant
TW201521766A (zh) * 2013-09-17 2015-06-16 Obi Pharma Inc 碳水化合物疫苗之化合物及組成物以及其用途

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2454853A1 (en) * 2001-08-14 2003-02-27 Biomira, Inc. Imunogenic conjugate of carbohydrate haptens and aggregated protein carrier

Patent Citations (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040208884A1 (en) * 1999-08-20 2004-10-21 Danishefsky Samuel J. Clustered multi-antigenic carbohydrate constructs, methods for their preparation, and uses thereof
EP1527081A1 (en) * 2002-07-31 2005-05-04 Sloan-Kettering Institute For Cancer Research Glyconjugates comprising carbohydrate epitopes, methods for theirsynthesis, and their use for the treatment or prophylaxis of cancer
US20100136042A1 (en) * 2008-06-16 2010-06-03 Chi-Huey Wong Globo h and related anti-cancer vaccines with novel glycolipid adjuvants
CN102065868A (zh) * 2008-06-16 2011-05-18 中央研究院 诱发对于Globo H及SSEA3的特异免疫反应的组合物以及其在癌症治疗中的用途
CN102215862A (zh) * 2009-06-16 2011-10-12 中央研究院 Globo h及含新颖糖脂质佐剂的相关抗癌疫苗
US20120237532A1 (en) * 2011-03-15 2012-09-20 Icon Genetics Gmbh Pharmaceutical formulation containing immunoglobulin
WO2014107652A2 (en) * 2013-01-04 2014-07-10 Obi Pharma Vaccines with higher carbohydrate antigen density and novel saponin adjuvant
TW201429488A (zh) * 2013-01-04 2014-08-01 Obi Pharma Inc 具有較高碳水化合物抗原密度之疫苗及新穎皂素佐劑
TW201521766A (zh) * 2013-09-17 2015-06-16 Obi Pharma Inc 碳水化合物疫苗之化合物及組成物以及其用途

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
LIEB,B.等: "《GenBank》", 26 November 2013 *
TERESA GILEWSKI等: "Immunization of metastatic breast cancer patients with a fully synthetic globo H conjugate:A phase I trial", 《PNAS》 *

Also Published As

Publication number Publication date
CA2961522A1 (en) 2016-03-24
IL251120B (en) 2021-05-31
TWI726850B (zh) 2021-05-11
SG11201702037SA (en) 2017-04-27
TW201628646A (zh) 2016-08-16
WO2016044326A9 (en) 2017-05-11
JP2017532310A (ja) 2017-11-02
EP3193919A4 (en) 2018-04-18
RU2017112982A (ru) 2018-10-17
BR112017005120A2 (pt) 2018-01-23
JP6774941B2 (ja) 2020-10-28
EP3193919B1 (en) 2020-04-08
RU2017112982A3 (ja) 2019-04-24
AU2015317889B2 (en) 2021-06-03
US20160339089A1 (en) 2016-11-24
IL251120A0 (en) 2017-04-30
CL2017000625A1 (es) 2018-02-02
BR112017005120B1 (pt) 2021-01-05
ES2797747T3 (es) 2020-12-03
KR20170090405A (ko) 2017-08-07
EP3193919A1 (en) 2017-07-26
PH12017500478A1 (en) 2017-07-10
MY188880A (en) 2022-01-12
AR101871A1 (es) 2017-01-18
AU2015317889A1 (en) 2017-04-13
KR20230109783A (ko) 2023-07-20
RU2720295C2 (ru) 2020-04-28
WO2016044326A1 (en) 2016-03-24

Similar Documents

Publication Publication Date Title
CN107427564A (zh) 免疫原性/治疗性糖缀合物组合物及其用途
CN110072545A (zh) 免疫原性/治疗性聚糖组合物及其用途
EP1379552B2 (en) Toll-like receptor 5 ligands and methods of use
TWI641383B (zh) 碳水化合物疫苗之化合物及組成物以及其用途
CN105535955B (zh) Globo h及含新颖糖脂质佐剂的相关抗癌疫苗
US8834872B2 (en) Uses of antibodies
AU2015322490B2 (en) Novel peptide and use thereof
TWI583393B (zh) 免疫原性組合物、包含其之疫苗與治療劑及其用途
US10098936B2 (en) Vaccination using plant virus particles linked to HER2 antigens

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
REG Reference to a national code

Ref country code: HK

Ref legal event code: DE

Ref document number: 1242225

Country of ref document: HK

REG Reference to a national code

Ref country code: HK

Ref legal event code: WD

Ref document number: 1242225

Country of ref document: HK